Mass General Hospital Cancer Center — Boston, Massachusetts

Mass General Hospital Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General Hospital Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Waldenstrom's Macroglobulinemia.

Sponsors: X4 Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Hospital Cancer Center?

Mass General Hospital Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Hospital Cancer Center conducted?

Mass General Hospital Cancer Center has 1 clinical trials on record. Their work covers Waldenstrom's Macroglobulinemia.

Is Mass General Hospital Cancer Center accredited by Crixeo Health?

Mass General Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.